Hubei Xingfa Chemicals Group Beheer

Beheer criteriumcontroles 4/4

De CEO Hubei Xingfa Chemicals Group is Long Shu, benoemd in May2006, heeft een ambtstermijn van 18.5 jaar. bezit rechtstreeks 0.016% van de aandelen van het bedrijf, ter waarde CN¥ 3.91M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.7 jaar en 4.5 jaar.

Belangrijke informatie

Long Shu

Algemeen directeur

CN¥930.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	18.5yrs
Eigendom CEO	0.02%
Management gemiddelde ambtstermijn	6.7yrs
Gemiddelde ambtstermijn bestuur	4.5yrs

Recente managementupdates

Recent updates

CEO

Long Shu (60 yo)

18.5yrs

Tenure

CN¥930,000

Compensatie

Mr. Long Shu serves as General Manager and Director of Hubei Xingfa Chemicals Group Co. Ltd. since May 2006.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Long Shu	GM & Director	18.5yrs	CN¥930.00k	0.016% CN¥ 3.9m
Chen Wang	Deputy GM & CFO	no data	CN¥964.30k	0.018% CN¥ 4.5m
Jie Wang	Executive Deputy GM & Director	no data	CN¥870.90k	0.013% CN¥ 3.2m
Boying Bao	Board Secretary	4.6yrs	CN¥790.00k	0.0082% CN¥ 2.1m
Chang Liu	Deputy General Manager	6.7yrs	CN¥1.27m	0.011% CN¥ 2.9m
Yong Zhao	Deputy General Manager	6.7yrs	CN¥1.57m	0.011% CN¥ 2.7m
Tie Jun Yang	Deputy General Manager	15.9yrs	CN¥1.07m	0.013% CN¥ 3.3m
Mingqing Lu	Deputy General Manager	4.6yrs	CN¥936.60k	0.011% CN¥ 2.6m
Qiao Zhang	Deputy General Manager	1.8yrs	CN¥972.60k	0.0067% CN¥ 1.7m

6.7yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 600141 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Long Shu	GM & Director	18.5yrs	CN¥930.00k	0.016% CN¥ 3.9m
Jie Wang	Executive Deputy GM & Director	4.5yrs	CN¥870.90k	0.013% CN¥ 3.2m
Guozhang Li	Chairman	18.5yrs	CN¥950.00k	0.023% CN¥ 5.7m
Zhong Hua Liu	Independent Director	3.5yrs	CN¥180.00k	geen gegevens
Ya Li Cheng	Director	9.6yrs	CN¥60.00k	0.011% CN¥ 2.7m
Kun Yi Hu	Vice Chairman	3.5yrs	CN¥990.00k	0.012% CN¥ 3.1m
Daqiao Cui	Independent Director	4.5yrs	CN¥180.00k	geen gegevens
Xiao Yan Zhang	Independent director	6.6yrs	CN¥180.00k	geen gegevens
Bing Yuan	Director	3.5yrs	CN¥60.00k	0.014% CN¥ 3.4m
Chunqian Jiang	Independent Director	3.5yrs	CN¥180.00k	geen gegevens
Xianjun Cao	Independent Director	3.5yrs	CN¥180.00k	geen gegevens
Xiangsen Wang	Chairman of the Supervisory Board	9.6yrs	geen gegevens	geen gegevens

4.5yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 600141 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).

Hubei Xingfa Chemicals Group Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.46 (vs CN¥0.35 in 3Q 2023)

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: EPS: CN¥0.39 (vs CN¥0.15 in 2Q 2023)

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Dividend of CN¥0.60 announced

New major risk - Financial position

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 16%

Hubei Xingfa Chemicals Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

Hubei Xingfa Chemicals' Controlling Shareholder Plans to Raise its Holdings in the Company

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023

New minor risk - Financial position

Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥1.73 in 2Q 2022)

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q2, 2023 Results on Aug 21, 2023

Full year 2022 earnings released: EPS: CN¥5.31 (vs CN¥3.85 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥1.17 (vs CN¥1.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.73 (vs CN¥0.70 in 2Q 2021)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥1.10 (vs CN¥0.22 in 3Q 2020)

Investor sentiment deteriorated over the past week

Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) signed an Equity Purchase Agreement to acquire additional 18.785% minority stake in Hubei Taisheng Chemical Co., Ltd. from ABC Financial Asset Investment Co., Ltd. for approximately CNY 510 million.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.70 (vs CN¥0.14 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.02 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.33 in FY 2019)

New 90-day high: CN¥14.78

New 90-day high: CN¥12.40

Third quarter earnings released

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2020 Results on Oct 16, 2020

Earnings released

New 90-day high - CN¥11.85

New 90-day high - CN¥10.59

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd